Annual Drug Patent Expirations for ROZLYTREK Rozlytrek is a drug marketed by Genentech Inc and is included in one NDA. It is available from one supplier. There are thirteen patents…
The post New patent for Genentech Inc drug ROZLYTREK appeared first on DrugPatentWatch - Make Better Decisions.